BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1998960)

  • 21. [Indication for hepatic resection after hepatic arterial infusion chemotherapy for multiple liver metastases of colorectal cancer].
    Takahashi K; Mori T; Yasuno M
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1834-7. PubMed ID: 11086424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isolated in situ liver perfusion with high dose 5-fluorouracil in the pig].
    Wang Y
    Zhonghua Wai Ke Za Zhi; 1990 Jan; 28(1):48-51, 62-3. PubMed ID: 2364817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacology of regional chemotherapy of colorectal liver metastases].
    Schalhorn A; Kühl M
    Zentralbl Chir; 1995; 120(10):764-8. PubMed ID: 7502590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.
    Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M
    Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice.
    Desgranges C; Razaka G; De Clercq E; Herdewijn P; Balzarini J; Drouillet F; Bricaud H
    Cancer Res; 1986 Mar; 46(3):1094-101. PubMed ID: 3943086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
    Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
    Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressin selectively increases 5-fluorouracil uptake by colorectal liver metastases following hepatic artery bolus infusion.
    Dietz DW; Casillas S; Jones SC; Milsom JW
    J Surg Res; 1998 Jul; 77(2):150-6. PubMed ID: 9733602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic arterial infusion with tumor necrosis factor-α induces early hepatic hyperperfusion.
    Schäfer T; Sperling J; Slotta JE; Kollmar O; Schilling MK; Menger MD; Richter S
    Eur Surg Res; 2012; 48(4):215-22. PubMed ID: 22739241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: II. High-dose cisplatin is well tolerated by the native lung tissue.
    Franke UF; Wittwer T; Kaluza M; Albert M; Becker V; Roskos M; Lessel M; Wahlers T
    Eur J Cardiothorac Surg; 2004 Oct; 26(4):800-6. PubMed ID: 15450576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.
    Marinelli A; van Dierendonck JH; van Brakel GM; Irth H; Kuppen PJ; Tjaden UR; van de Velde CJ
    Br J Cancer; 1991 Dec; 64(6):1069-75. PubMed ID: 1764369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
    Takanishi K; Matsumoto J; Minami T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1747-51. PubMed ID: 10560386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic artery infusion of doxorubicin with hepatic venous drug extraction.
    August DA; Verma N; Andrews JC; Vaerten MA; Brenner DE
    J Surg Res; 1994 Jun; 56(6):611-9. PubMed ID: 8015319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
    Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
    Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of conjugates of 2-fluoro-beta-alanine and bile acids during the metabolism of 5-fluorouracil and 5-fluoro-2-deoxyuridine in the isolated perfused rat liver.
    Sweeny DJ; Barnes S; Diasio RB
    Cancer Res; 1988 Apr; 48(8):2010-4. PubMed ID: 2964897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic uptake of amino acids immediately after liver transplantation is well preserved despite altered plasma profiles.
    Bradley AL; Sika M; Wright JK; Chapman WC; Blair KT; Jabbour K; Williams PE; Donovan KL; Van Buren DH; Flakoll PJ; Pinson CW
    J Surg Res; 1998 Jan; 74(1):47-53. PubMed ID: 9536973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized study.
    Fiorentini G; Cantore M; Rossi S; Vaira M; Tumolo S; Dentico P; Mambrini A; Bernardeschi P; Turrisi G; Giovanis P; Guadagni S; Valori V; De Simone M
    In Vivo; 2006; 20(6A):707-9. PubMed ID: 17203750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue levels of chemotherapeutic agents for hepatic metastasis during hepatic arterial and portal injection.
    Kaneko A; Naomoto Y; Aoyama M; Tanaka N
    In Vivo; 1999; 13(2):195-8. PubMed ID: 10363178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake, distribution, and elimination of carbon tetrachloride in rat tissues following inhalation and ingestion exposures.
    Sanzgiri UY; Srivatsan V; Muralidhara S; Dallas CE; Bruckner JV
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):120-9. PubMed ID: 9073600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.
    Sommadossi JP; Gewirtz DA; Cross DS; Goldman ID; Cano JP; Diasio RB
    Cancer Res; 1985 Jan; 45(1):116-21. PubMed ID: 3965128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.